Literature DB >> 27638098

Frequency and Effect of Access-Related Vascular Injury and Subsequent Vascular Intervention After Transcatheter Aortic Valve Replacement.

Ditte Dencker1, Mikkel Taudorf2, N H Vincent Luk3, Michael B Nielsen2, Klaus F Kofoed3, Torben V Schroeder4, Lars Søndergaard3, Lars Lönn5, Ole De Backer3.   

Abstract

Vascular access and closure remain a challenge in transcatheter aortic valve replacement (TAVR). This single-center study aimed to report the incidence, predictive factors, and clinical outcomes of access-related vascular injury and subsequent vascular intervention. During a 30-month period, 365 patients underwent TAVR and 333 patients (94%) were treated by true percutaneous transfemoral approach. Of this latter group, 83 patients (25%) had an access-related vascular injury that was managed by the use of a covered self-expanding stent (n = 49), balloon angioplasty (n = 33), or by surgical intervention (n = 1). In 16 patients (5%), the vascular injury was classified as a major vascular complication. Absence of a preprocedural computed tomography angiography (CTA) of the iliofemoral arteries (OR 2.04, p = 0.007) and female gender (OR 2.18, p = 0.004) were independent predictors of the need for access-related vascular intervention. In addition, a high sheath/common femoral artery ratio as measured on preoperative CTA was associated with a higher rate of post-TAVR vascular intervention. The radiation dose, iodine contrast volume, transfusion need, length of hospitalization, and 30-day mortality were not significantly different between patients with versus without access-related vascular intervention. In conclusion, access-related vascular intervention in patients who underwent transfemoral-TAVR is not uncommon. Female gender and a high sheath/common femoral artery ratio are risk factors for access-related vascular injury, whereas preprocedural planning with CTA of the access vessels may reduce the risk of vascular injury. Importantly, most access-related vascular injuries may be treated by percutaneous techniques with similar clinical outcomes to patients without vascular injuries.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27638098     DOI: 10.1016/j.amjcard.2016.07.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Characteristics of aorto-iliofemoral arterial tree according to aortic valve morphology in chinese patients considered for TAVR.

Authors:  Yuan Wang; Hasan Jilaihawi; Guanyuan Song; Moyang Wang; Bin Lv; Hao Wang; Guannan Niu; Zheng Zhou; Yongjian Wu
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-02       Impact factor: 2.357

2.  Iliofemoral Tortuosity Increases the Risk of Access-Site-Related Complications After Aortic Valve Implantation and Plug-Based Access-Site Closure.

Authors:  Arpad Lux; Lisa Müllenberg; Leo F Veenstra; Wim Dohmen; Suzanne Kats; Bart Maesen; Arnoud W J Van't Hof
Journal:  CJC Open       Date:  2022-03-19

Review 3.  Strategies for Facilitating Totally Percutaneous Transfemoral TAVR Procedures.

Authors:  Amnon Eitan; Hussein Sliman; Avinoam Shiran; Ronen Jaffe
Journal:  J Clin Med       Date:  2022-04-09       Impact factor: 4.964

Review 4.  Multidetector CT of iatrogenic and self-inflicted vascular lesions and infections at the groin.

Authors:  Massimo Tonolini; Anna Maria Ierardi; Gianpaolo Carrafiello; Domenico Laganà
Journal:  Insights Imaging       Date:  2018-04-19

5.  Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide.

Authors:  Pavel Hoffmann; Ahmed Al-Ani; Thomas von Lueder; Jenny Hoffmann; Peter Majak; Ove Hagen; Helga Loose; Nils Einar Kløw; Anders Opdahl
Journal:  CVIR Endovasc       Date:  2018-09-21

6.  Late Pseudoaneurysm After Access Site Closure with Manta in Transfemoral Aortic Valve Implantation.

Authors:  Pavel Hoffmann; Ahmed Al-Ani; Thomas von Lueder; Øyvind W Skoe; Thien T Tran; Anders Opdahl
Journal:  EJVES Short Rep       Date:  2018-11-06

7.  A Real World 10-Year Experience With Vascular Closure Devices and Large-Bore Access in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation.

Authors:  Gregor Heitzinger; Christina Brunner; Sophia Koschatko; Varius Dannenberg; Katharina Mascherbauer; Kseniya Halavina; Carolina Doná; Matthias Koschutnik; Georg Spinka; Christian Nitsche; Markus Mach; Martin Andreas; Florian Wolf; Christian Loewe; Christoph Neumayer; Michael Gschwandtner; Andrea Willfort-Ehringer; Max-Paul Winter; Irene M Lang; Philipp E Bartko; Christian Hengstenberg; Georg Goliasch
Journal:  Front Cardiovasc Med       Date:  2022-01-21

8.  Multi-Center Comparison of Two Self-Expanding Transcatheter Heart Valves: A Propensity Matched Analysis.

Authors:  Johannes Blumenstein; Clemens Eckel; Oliver Husser; Won-Keun Kim; Matthias Renker; Yeong-Hoon Choi; Christian W Hamm; Hani Al-Terki; Dagmar Sötemann; Leon Körbi; Vedat Tiyerili; Christina Grothusen; Luise Gaede; Guido Dohmen; Helge Möllmann
Journal:  J Clin Med       Date:  2022-07-21       Impact factor: 4.964

9.  Concurrent mechanical haemolytic anaemia and heparin-induced thrombocytopenia following transcatheter aortic valve replacement.

Authors:  Nathan W Furukawa; Fernando M Jumalon; Daniel B Friedman; Linda R Kelly
Journal:  BMJ Case Rep       Date:  2018-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.